PPT-Train-the-Trainer Understanding multidrug-resistance: Focus on

Carbapenems Customize this presentation with your organizations logo etc 1 3172014 Presentation Objectives Brief overview on microbiology and antibiotics Describe antibiotic resistant organisms with a focus on . Course Objectives. List the Criteria for Evaluation of Training. Explain the Need for Training and Development. Explain the Various Roles of a Trainer. Describe the Various Learning Styles and their Importance . MAINTAINING APPROPRIATE TRAINING RECORDS. 1. 2015-16 Driver Trainer Inservice. 2. Initial Requirements . Five years experience. Criminal record check. Authorized training course. Meet WAC requirements. 3 Day Intensive Training Course. Tools & Techniques to Enable Your Trainers to Deliver High Impact Trainings. Who We . A. re. We have trained over . 60,000 individuals across Asia.. Winners of . Brands Academy ET Now awards.. By Senior . Short . Term International Expert: . Kyriakos. . DIMITRIOU. Place: UCCI Tashkent Training Centre . Ташкент. . - . July 3, . 2014. Training of Trainers. Key points till now. Adult learning principles / Difficulties . Every Bit Fit Arizona is a leading personal training educator providing outstanding fitness training, in-home weight loss training and more service to customers in Mesa AZ. This train is bound for glory, this train.. This train is bound for glory,. Don't carry nothing . but the righteous and the holy.. This train is bound for glory, this train.. Oh, when the saints go marching in. P. Stogsdill, MD, FIDSA. Sept 2013. Bad bugs, No drugs. NO ESKAPE. E. nterococcus . faecium. S. taphylococcus . aureus. K. lebsiella. . pneumoniae. . C. lostridium. . difficile. A. cinetobacter. Resistance . (AMR. ). Antibiotics . have saved countless lives, but pathogens are quickly finding ways to survive antibiotic treatment. Antibiotic-resistant bacteria are predicted to become the leading cause of death worldwide, with an expected death rate of 10 million people, annually, by 2050.. Pérez-Lago L, Lirola M, Navarro Y, Herranz M, Ruiz-Serrano M, Bouza E, et al. Co-infection with Drug-Susceptible and Reactivated Latent Multidrug-Resistant Mycobacterium tuberculosis. Emerg Infect Dis. 2015;21(11):2098-2100. https://doi.org/10.3201/eid2111.150683. Last Updated: December 28, 2022. Prepared by:. David H. Spach, MD. Brian R. Wood, MD. Subcutaneous . Lenacapavir. Administer as Subcutaneous Injection. Take with or without food. Oral . Lenacapavir. Lenacapavir. Dierberg KL, Dorjee K, Salvo F, Cronin WA, Boddy J, Cirillo D, et al. Improved Detection of Tuberculosis and Multidrug-Resistant Tuberculosis among Tibetan Refugees, India. Emerg Infect Dis. 2016;22(3):463-468. https://doi.org/10.3201/eid2203.140732. CAPELLA. Lenacapavir. in Multidrug Resistant HIV. CAPELLA Study: Background. Source: Segal-Maurer S, et al. N . Engl. J Med. 2022;386:1793-1803. . Background. Phase 3, randomized, trial with oral and subcutaneous . John Stelling, MD, MPH, . jstelling@whonet.org. Brigham and Women’s Hospital, Harvard Medical School, Boston. WHO Collaborating Centre for Surveillance of Antimicrobial Resistance. Webinar agenda. Comments on the WHONET Webinar series. Kariuki S, Gilks C, Revathi G, Hart CA. Genotypic Analysis of Multidrug-Resistant Salmonella enterica Serovar Typhi, Kenya. Emerg Infect Dis. 2000;6(6):649-651. https://doi.org/10.3201/eid0606.000616.